Adaptive Biotechnologies (ADPT) Change in Inventory (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Change in Inventory data on file, last reported at $1.3 million in Q1 2026.

• Quarterly Change in Inventory rose 598.11% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 156.95% YoY) and the FY2025 annual result came in at $998000.0, up 118.58% from the prior year.
• Change in Inventory grew to $1.3 million in Q1 2026 per ADPT's latest filing, from $10000.0 in the prior quarter.
• The five-year high for Change in Inventory was $6.6 million in Q1 2023, with the low at -$4.0 million in Q4 2023.
• Average Change in Inventory over 5 years is -$61058.8, with a median of -$65000.0 recorded in 2023.
• The widest YoY moves for Change in Inventory: up 1358.46% in 2024, down 721.61% in 2024.
• Adaptive Biotechnologies' Change in Inventory stood at -$3.0 million in 2022, then tumbled by 31.3% to -$4.0 million in 2023, then grew by 14.96% to -$3.4 million in 2024, then jumped by 100.3% to $10000.0 in 2025, then soared by 13050.0% to $1.3 million in 2026.
• Business Quant data shows ADPT's Change in Inventory at $1.3 million in Q1 2026, $10000.0 in Q4 2025, and $1.3 million in Q3 2025.